StockNews.com Upgrades Nu Skin Enterprises (NYSE:NUS) to “Buy”

Nu Skin Enterprises (NYSE:NUSGet Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Wednesday.

Separately, TheStreet upgraded shares of Nu Skin Enterprises from a “c+” rating to a “b” rating in a report on Tuesday, June 7th. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $61.50.

Shares of Nu Skin Enterprises stock opened at $45.55 on Wednesday. Nu Skin Enterprises has a 1 year low of $39.40 and a 1 year high of $58.97. The company has a market cap of $2.29 billion, a P/E ratio of 16.87 and a beta of 1.23. The company has a current ratio of 1.72, a quick ratio of 0.95 and a debt-to-equity ratio of 0.28. The stock has a 50-day moving average price of $45.47 and a 200 day moving average price of $48.05.

Nu Skin Enterprises (NYSE:NUSGet Rating) last posted its quarterly earnings results on Wednesday, May 4th. The company reported $0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.73 by $0.03. Nu Skin Enterprises had a net margin of 5.28% and a return on equity of 22.05%. The business had revenue of $604.90 million during the quarter, compared to analyst estimates of $579.70 million. During the same period in the prior year, the firm earned $0.91 earnings per share. The firm’s revenue was down 10.7% compared to the same quarter last year. On average, equities analysts forecast that Nu Skin Enterprises will post 3.8 earnings per share for the current fiscal year.

In other news, CEO Ryan S. Napierski sold 25,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Wednesday, May 25th. The shares were sold at an average price of $44.91, for a total value of $1,122,750.00. Following the transaction, the chief executive officer now owns 122,683 shares of the company’s stock, valued at $5,509,693.53. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Chairman Steven Lund sold 17,129 shares of the company’s stock in a transaction on Thursday, June 23rd. The stock was sold at an average price of $45.18, for a total transaction of $773,888.22. Following the sale, the chairman now directly owns 20,800 shares of the company’s stock, valued at $939,744. The disclosure for this sale can be found here. Insiders have sold a total of 148,143 shares of company stock worth $6,652,437 in the last 90 days. 2.80% of the stock is owned by insiders.

Several large investors have recently modified their holdings of NUS. TCI Wealth Advisors Inc. lifted its position in shares of Nu Skin Enterprises by 66.6% during the 4th quarter. TCI Wealth Advisors Inc. now owns 758 shares of the company’s stock worth $38,000 after purchasing an additional 303 shares during the last quarter. Covestor Ltd acquired a new position in shares of Nu Skin Enterprises during the fourth quarter worth approximately $48,000. Quadrant Capital Group LLC boosted its position in shares of Nu Skin Enterprises by 47.1% in the fourth quarter. Quadrant Capital Group LLC now owns 1,068 shares of the company’s stock valued at $54,000 after acquiring an additional 342 shares during the period. JJJ Advisors Inc. grew its stake in shares of Nu Skin Enterprises by 216.9% in the fourth quarter. JJJ Advisors Inc. now owns 1,870 shares of the company’s stock worth $95,000 after acquiring an additional 1,280 shares during the last quarter. Finally, Gladius Capital Management LP acquired a new position in Nu Skin Enterprises during the 4th quarter valued at $98,000. 93.79% of the stock is currently owned by institutional investors.

About Nu Skin Enterprises (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Read More

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.